Found 5 matching trials
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis PHASE1 This study will evaluate the safety of the Leish-111f + MPL-SE vaccine in a...
Show More Location
Universidade Federal de Minas Gerais
Learn More & Join Trial
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis PHASE1 The purpose of this study is to evaluate the safety of the Leish-111f + MPL...
Show More Location
Clínica de Leishmaniasis, Hospital Nacional Sur Este EsSalud
Learn More & Join Trial
Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India PHASE1 The purpose of this study is to determine if a vaccine (called Leish-111f +...
Show More Location
Banaras Hindu University
Learn More & Join Trial
Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite PHASE2 This study will evaluate the safety and immunogenicity of the Leish-111f + ...
Show More Location
Programa de Estudio y Control de Enfermedades Tropicales (PECET)
Learn More & Join Trial
Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite PHASE1 This study will evaluate the safety of the Leish-111f + MPL-SE vaccine in a...
Show More Location
Programa de Estudio y Control de Enfermedades Tropicales (PECET)
Learn More & Join Trial